pI: 7.0406 |
Length (AA): 514 |
MW (Da): 57525 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 7 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
154 | 512 | 1nv8 (A) | 12 | 279 | 26.00 | 0 | 1 | 0.51 | 0.52 |
272 | 404 | 1l3i (A) | 3 | 133 | 19.00 | 0.000000051 | 0.41 | 0.49 | -0.6 |
202 | 511 | 1nv8 (A) | 31 | 278 | 27.00 | 0 | 1 | 0.596913 | 0.59 |
203 | 506 | 2b3t (A) | 20 | 269 | 26.00 | 0 | 1 | 0.60524 | 0.59 |
305 | 347 | 3d2l (A) | 35 | 74 | 43.00 | 0.48 | 0.31 | 0.404558 | 0.64 |
305 | 347 | 3bxo (A) | 41 | 81 | 24.00 | 0 | 0.08 | 0.198458 | 0.67 |
305 | 391 | 3mgg (A) | 38 | 136 | 33.00 | 0.000018 | 0.71 | 0.514161 | -0.8 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | metacyclic. | Fernandes MC |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | amastigotes. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_128078)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G64150 | RNA methyltransferase family protein |
Candida albicans | CaO19.499 | similar to S. cerevisiae YNL063W |
Candida albicans | CaO19.8129 | similar to S. cerevisiae YNL063W |
Chlamydia trachomatis | CT_024 | release factor glutamine methyltransferase |
Dictyostelium discoideum | DDB_G0278505 | hypothetical protein |
Drosophila melanogaster | Dmel_CG9531 | CG9531 gene product from transcript CG9531-RA |
Escherichia coli | b1212 | N5-glutamine methyltransferase, modifies release factors RF-1 and RF-2 |
Homo sapiens | ENSG00000114735 | HemK methyltransferase family member 1 |
Leishmania braziliensis | LbrM.35.4730 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_364710.1 | hypothetical protein, conserved |
Leishmania infantum | LinJ.36.4710 | hypothetical protein, conserved |
Leishmania major | LmjF.36.4490 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.36.4490 | hypothetical protein, conserved |
Mycobacterium leprae | ML1135 | PROBABLE PROTOPORHYRINOGEN OXIDASE HEMK HOMOLOG |
Mus musculus | ENSMUSG00000032579 | HemK methyltransferase family member 1 |
Mycobacterium tuberculosis | Rv1300 | Probable HemK protein homolog HemK |
Mycobacterium ulcerans | MUL_3964 | modification methylase HemK |
Oryza sativa | 4352776 | Os12g0612500 |
Saccharomyces cerevisiae | YNL063W | Mtq1p |
Schmidtea mediterranea | mk4.075522.01 | |
Schmidtea mediterranea | mk4.005663.00 | HemK methyltransferase family member 1 |
Trypanosoma brucei gambiense | Tbg972.10.12030 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.10.9860 | Mitochondrial N(5)-glutamine methyltransferase MTQ1, putative |
Trypanosoma congolense | TcIL3000_10_8510 | Mitochondrial N(5)-glutamine methyltransferase MTQ1, putative |
Trypanosoma cruzi | TcCLB.504147.40 | Mitochondrial N(5)-glutamine methyltransferase MTQ1, putative |
Treponema pallidum | TP0052 | protoporphyrinogen oxidase (hemK) |
Wolbachia endosymbiont of Brugia malayi | Wbm0285 | methylase of polypeptide chain release factor |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu1322 | Mycobacterium tuberculosis | essential | nmpdr |
Tb927.10.9860 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.9860 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.9860 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.9860 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b1212 | Escherichia coli | essential | goodall |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.